By Sally Adams
Dec 24, 2020
Many families are taking their loved ones out of Assisted Living and Nursing Facilities for fear of infection and the sadness of isolation. Mark Mullahy of Holly Hall Retirement Community hasn t seen a fall-off, though. His staff practices the same anti-Covid routine in their private lives they observe at work. And they actively fight isolation. We set up regular face-time calls. We go into a resident s room. We initiate a face-time call and let them have their privacy.and then go on to the next resident s visit., says Mullahy.
The decline in other nursing-home resident numbers is causing such an income loss, some economists are predicting a change in the industry. The Nursing Home industry is seeing a loss in residents because people are in fear of their parent living in a possible Covid infestation and the isolation it brings. Some companies say they might be going out of business. Mullahy says they haven t seen a drop off, probably becaus
By Sally Adams
Dec 24, 2020
Many families are taking their loved ones out of Assisted Living and Nursing Facilities for fear of infection and the sadness of isolation. Mark Mullahy of Holly Hall Retirement Community hasn t seen a fall-off, though. His staff practices the same anti-Covid routine in their private lives they observe at work. And they actively fight isolation. We set up regular face-time calls. We go into a resident s room. We initiate a face-time call and let them have their privacy.and then go on to the next resident s visit., says Mullahy.
The decline in other nursing-home resident numbers is causing such an income loss, some economists are predicting a change in the industry. The Nursing Home industry is seeing a loss in residents because people are in fear of their parent living in a possible Covid infestation and the isolation it brings. Some companies say they might be going out of business. Mullahy says they haven t seen a drop off, probably becaus
DGAP-News: AIM I .
DGAP-News: AIM ImmunoTech Inc: AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers
vom 24.12.2020, 14:15 Uhr
Bild: pixabay.com
DGAP-News: AIM ImmunoTech Inc / Key word(s): Miscellaneous
AIM ImmunoTech Inc: AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers
24.12.2020 / 14:15
The issuer is solely responsible for the content of this announcement.
AIM ImmunoTech Announces that the ME/CFS Clinical Trial of its Drug Ampligen is Open for Enrollment to COVID-19 Long Haulers
Institutional Review Board Authorizes Solicitation for Enrollment of Subjects
AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 'Long Haulers' Institutional Review Board Authorizes Public Notification for Potential
Thursday, 24 December 2020 - 7:47
The official Sputnik V Twitter account as well as foreign media has announced Wednesday that Argentina is the first country in Latin America to officially register the Covid-19 vaccine. Argentina was the first country in Latin America to officially register Sputnik V. The vaccine was registered under the emergency use authorization procedure and was approved by the regulator, ANMAT, based on the results of Phase III clinical trials in Russia, without additional trials in Argentina, the RDIF statement said. The registration confirms high confidence in Russian regulatory standards and Sputnik V, the Sputnik V tweet said.
Argentina Health Minister Gines González García tweeted Wednesday that an Aerolineas flight has arrived in Moscow and will bring back 300,000 of the first doses of Russia s Sputnik V vaccine.